Dr. Bassel Nazha, MD, MPH
Claim this profileEmory University Hospital/Winship Cancer Institute
Area of expertise
Kidney Cancer
Bassel Nazha, MD, MPH has run 3 trials for Kidney Cancer. Some of their research focus areas include:
Prostate Cancer
Bassel Nazha, MD, MPH has run 2 trials for Prostate Cancer. Some of their research focus areas include:
Affiliated Hospitals
Emory University Hospital/Winship Cancer Institute
Emory University Hospital Midtown
Clinical Trials Bassel Nazha, MD, MPH is currently running
Enfortumab Vedotin + Pembrolizumab
for Advanced Bladder Cancer
This phase II trial tests how well enfortumab vedotin (EV) and pembrolizumab works in treating patients with bladder cancer of variant histology (a group of less common types of bladder cancer) that have spread to nearby tissue or lymph nodes (locally advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic). Enfortumab vedotin is a monoclonal antibody, enfortumab, linked to an anticancer drug called vedotin. Enfortumab attaches to a protein called nectin-4 on cancer cells in a targeted way and delivers vedotin to kill them. It is a type of antibody-drug conjugate. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving enfortumab vedotin and pembrolizumab may kill more tumor cells in patients with locally advanced or metastatic bladder cancer of variant histology.
Recruiting
1 award
Phase 2
16 criteria
Durvalumab + Chemotherapy
for Urothelial Carcinoma
This phase II/III trial compares the effect of adding durvalumab to chemotherapy versus chemotherapy alone before surgery in treating patients with upper urinary tract cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as methotrexate, vinblastine, doxorubicin, cisplatin, and gemcitabine work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Durvalumab in combination with chemotherapy before surgery may enhance the shrinking of the tumor compared to chemotherapy alone.
Recruiting
1 award
Phase 2 & 3
10 criteria
More about Bassel Nazha, MD, MPH
Clinical Trial Related
2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Bassel Nazha, MD, MPH has experience with
- Pembrolizumab
- Atezolizumab
- Cabozantinib
- Lenvatinib
- Doxorubicin Hydrochloride
- Vinblastine Sulfate
Breakdown of trials Bassel Nazha, MD, MPH has run
Kidney Cancer
Prostate Cancer
Urothelial Carcinoma
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Bassel Nazha, MD, MPH specialize in?
Bassel Nazha, MD, MPH focuses on Kidney Cancer and Prostate Cancer. In particular, much of their work with Kidney Cancer has involved Stage IV patients, or patients who are FH positive.
Is Bassel Nazha, MD, MPH currently recruiting for clinical trials?
Yes, Bassel Nazha, MD, MPH is currently recruiting for 3 clinical trials in Atlanta Georgia. If you're interested in participating, you should apply.
Are there any treatments that Bassel Nazha, MD, MPH has studied deeply?
Yes, Bassel Nazha, MD, MPH has studied treatments such as Pembrolizumab, Atezolizumab, Cabozantinib.
What is the best way to schedule an appointment with Bassel Nazha, MD, MPH?
Apply for one of the trials that Bassel Nazha, MD, MPH is conducting.
What is the office address of Bassel Nazha, MD, MPH?
The office of Bassel Nazha, MD, MPH is located at: Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia 30322 United States. This is the address for their practice at the Emory University Hospital/Winship Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.